Site specific alkylating agents
    3.
    发明授权
    Site specific alkylating agents 失效
    现场特异性烷化剂

    公开(公告)号:US5310752A

    公开(公告)日:1994-05-10

    申请号:US925408

    申请日:1992-08-10

    CPC分类号: C07D409/12 C07D207/34

    摘要: The invention relates to distamycin A analogs of the following formula ##STR1## wherein n is 2, 3 or 4; A is an optionally substituted divalent radical chosen from ##STR2## and --Het-- wherein Het is a pentatomic or hexatomic heteromonocyclic ring, except pyrrole; and wherein either one of R.sub.1 and R.sub.2 is hydrogen and the other is an acylating moiety or R.sub.1 and R.sub.2 are both hydrogen or both alkyl groups optionally substituted, including the pharmaceutically acceptable salts of the said compounds.The compounds of the invention can be useful antitumor and antiviral agents.

    摘要翻译: 本发明涉及下列式的分心霉素A类似物:其中n为2,3或4; A是选自以下的任选取代的二价基团:其中Het是五原子或六原子异单环,除了吡咯; 并且其中R 1和R 2中的任一个是氢,而另一个是酰化部分或R 1和R 2都是氢或任选被取代的两个烷基,包括所述化合物的药学上可接受的盐。 本发明的化合物可以是有用的抗肿瘤剂和抗病毒剂。

    Site specific alkylating agents
    4.
    发明授权
    Site specific alkylating agents 失效
    现场特异性烷化剂

    公开(公告)号:US5049579A

    公开(公告)日:1991-09-17

    申请号:US607339

    申请日:1990-10-31

    IPC分类号: C07D207/34 C07D409/12

    CPC分类号: C07D409/12 C07D207/34

    摘要: The invention relates to distamycin A analogs of the following formula ##STR1## wherein n is 2, 3 or 4; A is an optionally substituted divalent radical chosen from ##STR2## and -Het- wherein Het is a pentatomic or hexatomic heteromonocyclic ring, except pyrrole; and wherein either one of R.sub.1 and R.sub.2 is hydrogen and the other is an acylating moiety or R.sub.1 and R.sub.2 are both hydrogen or both alkyl groups optionally substituted, including the pharmaceutically acceptable salts of the said compounds.The compounds of the invention can be useful antitumor and antiviral agents.

    摘要翻译: 本发明涉及下列式的分心霉素A类似物:其中n为2,3或4; A是选自以下的任选取代的二价基团:其中Het是五原子或六原子异单环,除了吡咯; 并且其中R 1和R 2中的任一个是氢,而另一个是酰化部分或R 1和R 2都是氢或任选被取代的两个烷基,包括所述化合物的药学上可接受的盐。 本发明的化合物可以是有用的抗肿瘤剂和抗病毒剂。